Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-30
2011-12-06
Dell, David K O (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S278000
Reexamination Certificate
active
08071773
ABSTRACT:
The patent application relates to new heterocyclic compounds of the general formula (I) in which R, R1, R2, W, X, Y, Z and n have the definitions elucidated in more detail in the description, to a process for preparing them and to the use of these compounds as medicaments, particularly as aldosterone synthase inhibitors.
REFERENCES:
patent: 01/76574 (2001-10-01), None
patent: 2004/014914 (2004-02-01), None
patent: 2004/046145 (2004-06-01), None
Online: “Calculating the Degrees of Unsaturation From a Compound's Molecular Formula” from Organic Chemistry handouts Department of Chemistry Manhattanville College “http://faculty.mville.edu/ParikhS/courses/chm2001/docs/Handouts/Degree%20of%20unsaturation.pdf” accessed Nov. 20, 2010.
Browne et. al. “Fadrozole Hydrochloride: A Potent, Selective, Nonsteroidal Inhibitor of Aromatase for the Treatment of Estrogen-Dependent Disease” Journal of Medicinal Chemistry 1991, 34, 725-736.
Ulmschneider et. al. “Synthesis and Evaluation of (Pyridylmethylene)tetrahydronaphthalenes/-indanes and Structurally Modified Derivatives: Potent and Selective Inhibitors of Aldosterone Synthase” Journal of Medicinal Chemistry 2005, 48, 1563-1575.
Ulmschneider et. al. “Synthesis and Evaluation of Imidazolylmethylenetetrahydronaphthalenes and Imidazolylmethyleneindanes: Potent Inhibitors of Aldosterone Synthase” Journal of Medicinal Chemistry 2005, 1796-1805.
International Search Report issued Aug. 10, 2006 in the International (PCT) Application PCT/EP2006/062696 of which the present application is the U.S. National Stage.
Herold Peter
Jotterand Nathalie
Mah Robert
Marti Christiane
Quirmbach Michael
Dell David K O
NovartisAG
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Heterocyclic spiro-compounds as aldosterone synthase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic spiro-compounds as aldosterone synthase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic spiro-compounds as aldosterone synthase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4293402